NEW YORK AND LONDON
Celsus Therapeutics(OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announced today the addition of biopharmaceutical industry veteran Allan Shaw to the Company’s Board of Directors. Mr. Shaw will serve as Chairman of the Audit Committee.